Mechanistic investigation of drug release from asymmetric membrane tablets:: Effect of media gradients (osmotic pressure and concentration), and potential coating failures on in vitro release

被引:13
作者
Ende, Mary Tanya am [1 ]
Miller, Lee A. [1 ]
机构
[1] Pfizer Inc, Groton, CT 06340 USA
关键词
asymmetric membrane tablets; controlled release; in vitro performance; intentional defects in coating; osmotic and diffusional drug delivery;
D O I
10.1007/s11095-006-9142-y
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Purpose. An asymmetric membrane (AM) tablet was developed for a soluble model compound to study the in vitro drug release mechanisms in challenge conditions, including osmotic gradients, concentration gradients, and under potential coating failure modes. Porous, semipermable membrane integrity may be compromised by a high fat meal or by the presence of a defect in the coating that could cause a safety concern about dose-dumping. Methods. The osmotic and diffusional release mechanisms of the AM tablet were independently shut down such that their individual contribution to the overall drug release was measured. Shut off of osmotic and diffusional release was accomplished by performing dissolution studies into receptor solutions with osmotic pressure above the internal core osmotic pressure and into receptor solutions saturated with drug, respectively. The effect of coating failure modes on in vitro drug release from the AM tablet was assessed through a simulated high-fat meal and by intentionally compromising the coating integrity. Results. The predominant drug release mechanism for the AM tablet was osmotic and accounted for approximately 90-95% of the total release. Osmotic release was shutoff when the receptor media osmotic pressure exceeded 76 atm. Diffusional release of the soluble drug amounted to 5-10% of the total release mechanism. The observed negative in vitro food effect was attributed to the increased osmotic pressure from the high fat meal when compared to the predicted release rates in sucrose media with the same osmotic pressure. This suppression in drug release rate due to a high fat meal is not anticipated to affect in vivo performance of the dosage form, as the rise in pressure is short-lived. Conclusions. Drug release from the AM system studied was determined to be robust to varying and extreme challenge conditions. The conditions investigated included varying pH, agitation rate, media osmotic pressure, media saturated with drug to eliminate the concentration gradient, simulated high fat meal, and intentionally placed film coating defects. Osmotic and diffusional shut off experiments suggest that the mechanism governing drug release is a combination of osmotic and diffusional at approximately 90-95% and 5-10%, respectively. In addition, the coating failure mode studies revealed this formulation and design is not significantly affected by a high fat meal or by an intentionally placed defect in the film coating, and more specifically, did not result in a burst of drug release.
引用
收藏
页码:288 / 297
页数:10
相关论文
共 20 条
[1]
AMENDE MT, 2000, HDB PHARM CONTROLLED, P751
[2]
[Anonymous], [No title captured], Patent No. [4,968,507, 4968507]
[3]
USE OF MODIFIED ETHYLCELLULOSE LATTICES FOR MICROPOROUS COATING OF OSMOTIC TABLETS [J].
APPEL, LE ;
ZENTNER, GM .
PHARMACEUTICAL RESEARCH, 1991, 8 (05) :600-604
[4]
Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs): Discovery of capromorelin [J].
Carpino, PA ;
Lefker, BA ;
Toler, SM ;
Pan, LC ;
Hadcock, JR ;
Cook, ER ;
DiBrino, JN ;
Campeta, AM ;
DeNinno, SL ;
Chidsey-Frink, KL ;
Hada, WA ;
Inthavongsay, J ;
Mangano, FM ;
Mullins, MA ;
Nickerson, DF ;
Ng, OC ;
Pirie, CM ;
Ragan, JA ;
Rose, CR ;
Tess, DA ;
Wright, AS ;
Yu, L ;
Zawistoski, MP ;
DaSilva-Jardine, PA ;
Wilson, TC ;
Thompson, DD .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (04) :581-590
[5]
CHIDLAW M, 2004, Patent No. 2004052343
[6]
IONIC CONSTITUENTS AND OSMOLALITY OF GASTRIC AND SMALL-INTESTINAL FLUIDS AFTER EATING [J].
FORDTRAN, JS ;
LOCKLEAR, TW .
AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1966, 11 (07) :503-&
[7]
ASYMMETRIC-MEMBRANE TABLET COATINGS FOR OSMOTIC DRUG-DELIVERY [J].
HERBIG, SM ;
CARDINAL, JR ;
KORSMEYER, RW ;
SMITH, KL .
JOURNAL OF CONTROLLED RELEASE, 1995, 35 (2-3) :127-136
[8]
MASS-TRANSPORT IN DISSOLUTION KINETICS .1. CONVECTIVE DIFFUSION TO ASSESS THE ROLE OF FLUID VISCOSITY UNDER FORCED FLOW CONDITIONS [J].
NELSON, KG ;
SHAH, AC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (10) :799-802
[9]
Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-β-CD [J].
Okimoto, K ;
Miyake, M ;
Ohnishi, N ;
Rajewski, RA ;
Stella, VJ ;
Irie, T ;
Uekama, K .
PHARMACEUTICAL RESEARCH, 1998, 15 (10) :1562-1568
[10]
Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-β-cyclodextrin as both a solubilizing and an osmotic pump agent [J].
Okimoto, K ;
Rajewski, RA ;
Stella, VJ .
JOURNAL OF CONTROLLED RELEASE, 1999, 58 (01) :29-38